Table 1 Baseline characteristics of study population
Patient characteristics | Patients (n = 90) |
|---|---|
Male (number, %) | 44 (48.9%) |
Age at diagnosis (median, range; years) | 38 (11–69) |
Disease follow-up period (median, range; years) | 11.8 (0.3–38.4) |
Duration between diagnosis and surgery (median, range; months) | 23 (0–217) |
Subtype of disease | |
Definite | 68 (75.6%) |
Probable | 2 (2.2%) |
Suspected | 20 (22.2%) |
Oral ulcers | 66 (73.3%) |
Genital ulcers | 31 (34.4%) |
Skin manifestations | 30 (33.3%) |
Typical intestinal ulcers | 86 (95.6%) |
Fistula / abscess | 11 (12.2%)/4 (4.4%) |
Perioperative medical treatment (number; %) | |
5-aminosalicylic acids | 86 (95.6%) |
Immunomodulator | 53 (58.9%) |
Azathioprine | 43 (47.8%) |
6-Mercaptopurine | 3 (3.3%) |
Methotrexate | 7 (7.8%) |
Colchicine | 45 (50.0%) |
Corticosteroids | 74 (82.2%) |
Anti-TNF antagonist | 12 (13.3%) |
Surgical technique (number; %) | |
Laparoscopy | 40 (44.4%) |
Open | 50 (55.6%) |
Emergent surgery | 13 (14.4%) |
CRP (mg/L) | 57.0 ± 71.2 |
Day of CRP measurement after surgery (median, interquartile range; days) | 2 (1–4) |